Division of Hematology & Hematologic Malignancies

The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.

Latest News

Congratulations to Dr. Ahmad Halwani
Recognition
Jul 11, 2018

Congratulations to Dr. Ahmad Halwani

Congratulations to Dr. Ahmad Halwani who was recently selected by the National Cancer Institute to receive a Cancer Clinical Investigator Team Leadership award. This award recognizes his contributions to clinical cancer research and will support his ongoing research and leadership development. Dr. Halwani specializes in the treatment of blood-related cancers, including lymphoma and leukemia. He and his colleagues use electronic healthcare records to research better treatment practices for oncology patients.... Read More

Internal Medicine
Congratulations to Dr. Djordje Atanackovic
Recognition
Jun 13, 2018

Congratulations to Dr. Djordje Atanackovic

Dr. Djordje Atanackovic was selected for the Society of Huntsman Translational Scholars. This program has been established to honor HCl's clinician community of distinguished translational investigators, to support the translational research efforts of Society members, and to develop a forum for mentorship and sponsorship of translational investigators at HCI. Dr. Atanackovic will hold the scholarship position for a three-year term. As a member of this society, Dr. Atanackovic will serve as an informal advisory board to HCI’s Senior Leadership.... Read More

Internal Medicine
Hematology Research Symposium at Deer Valley
Education
May 22, 2018

Hematology Research Symposium at Deer Valley

The Hematology Research Symposium on June 8-9, 2018 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy, genomics in hematologic malignancies, and more. ... Read More

Internal Medicine
Deininger appointed Director of HCI Center of Excellence
Recognition
May 03, 2018

Deininger appointed Director of HCI Center of Excellence

Congratulations to Mike Deininger, MD, PhD, for his appointment as Director of the Huntsman Center of Excellence in Hematological Malignancies and Hematology. This Center supported by investments from the Departments of Internal Medicine and Pathology, the Senior Vice President for Health Sciences, and HCI will enable vigorous recruitment of additional faculty and will support research infrastructure to advance translational research and clinical care in this critical area. HCI’s Centers of Excellence serve as hubs for multidisciplinary cancer care with full integration of clinical care, education, and research, including investigator-initiated clinical trials and other patient-oriented research designed to reduce morbidity and mortality. Dr. Deininger will continue to serve as Chief of the Division of Hematology and Hematological Malignancies in the Department of Internal Medicine.... Read More

Internal Medicine
Dr. Paul Bray Recipient of NIH Grant
Research
Apr 20, 2018

Dr. Paul Bray Recipient of NIH Grant

Congratulations to Dr. Paul Bray for his award of a NIH grant from the National Heart, Lung, and Blood Institute. The grant awarded from 2018 through 2022 is focused on in vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation. The goal of Dr. Bray’s studies is to glean insights into the molecular genetic mechanisms that contribute to blood platelet formation and function. Dr. Bray and his team will investigate the role of microRNA regulation of megakaryocyte gene expression and test the hypothesis that specific microRNAs modulate the development of megakaryocytes into platelets and platelet function. One additional aspect of their studies will be testing whether microRNAs can enhance the in vitro production of platelets as a potential therapeutic for thrombocytopenia and thrombocytosis.... Read More

Internal Medicine

MESSAGE FROM OUR CHIEF

Deininger


Welcome to the Division of Hematology and Hematologic Malignancies! The scientific focus of our Division is the study of blood and bone marrow in health and disease.

Read More

Upcoming Events

View Calendar

Help Progress, Give Today

You can help the Division of Hematology continue to progress with even a small contribution.

Give Today!